9 hrs ago | Bloomberg Business News
Arthritis Drugs Need Tougher Infection Warnings After 45 Deaths, U.S. Says
Arthritis and autoimmune drugs marketed by Amgen Inc. , Wyeth and Johnson & Johnson must carry stronger warnings about fungal infections tied to more than 45 deaths, U.S. regulators said.
Medical Device/Diagnostic Ind.
James M. Gibson Jr., an expert on medical device sterilization who served for a number of years on MD&DI 's Editorial Advisory Board, passed away on August 1. He worked for Johnson & Johnson and Abbott ...
Stent Investigation Undermines J&J, Abbott, Boston Scientific Income Goals
A $1.8 billion market for metal tubes used to clear blocked arteries outside the heart may be upended by a U.S. probe into marketing practices by Johnson & Johnson , Boston Scientific Corp.
Drug and medical device maker Abbott Laboratories plans to close its South Pasadena facility as part of a companywide restructuring.
AngioScore eyes Abbott catheter patent
AngioScore Inc. is petitioning the Food and Drug Administration to refuse competitor Abbott Laboratories the extension of its patent covering so-called "rapid exchange" angioplasty catheters.
Owning Abbott shares a 'badge of honor'
Owning Abbott shares a 'badge of honor' August 23, 2008 DEAR SCOTT: You haven't written about Abbott Laboratories in awhile.
National And International Report / New jobless claims fall more than expected, remain high
The number of newly laid-off workers seeking unemployment benefits fell more than expected last week, the second straight drop from a six-year high, according to government data released Thursday.
Abbott to cut 1,000 jobs from diagnostic unit
Drug and medical device maker Abbott Laboratories said Thursday it will cut 1,000 jobs as part of a multiyear effort to lower spending on its medical testing business.
Abbott to cut 1,000 jobs from diagnostic unit
Drug and medical device maker Abbott Laboratories will cut 1,000 jobs as part of a multiyear effort to lower spending on its medical testing business.
Abbott to cut 1,000 jobs from diagnostic unit
Drug and medical device maker Abbott Laboratories said Thursday it will cut 1,000 jobs as part of a multiyear effort to lower spending on its medical testing business.
Abbott to Take $370 Million in Charges to Close Factories, Fire Employees
Abbott Laboratories said it expects to take $370 million in charges to close factories, fire employees and transfer work in its global operations.
Abbott, AstraZeneca co-market cholesterol drug
Drug maker Abbott Laboratories will co-promote the cholesterol drug Crestor in the U.S. after Abbot expanded its relationship with AstraZeneca PLC, the companies said Thursday.
Before becoming a jewelry designer, I got a chemistry degree and spent three years at Abbott Laboratories doing diagnostic testing on a virus that attacks the immune system.
Johnson & Johnson Receives U.S. Subpoena Over Marketing of Biliary Stents
Johnson & Johnson said it was subpoenaed by the U.S. Justice Department in connection with its sales of bile duct stents, broadening a probe that has touched competitors Abbott Laboratories and Boston ...
Abbott Laboratories Study Shows Investigational Heat-Stable Norvir(R) ...
Abbott presented pivotal data at the XVII International AIDS Conference in Mexico City today showing that its investigational Norvir tablet and the current soft-gelatin capsule provide similar levels of drug ...
Don't wait for a stock split. Diversify your investments
Q: I've had all my money in Abbott Laboratories stock for about 12 years, since inheriting the stock.
The Alkaloid Conessine and Analogues as Potent Histamine H3 Receptor Antagonists
Department of Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6123 Received March 31, 2008 Abstract: The naturally ...
Abbott Faces Onslaught of Lawsuits for HIV Drugs
When Abbott Laboratories Inc. hiked up the price of a popular AIDS drug by 400 percent in 2003, executives prepared for the inevitable public relations hit, but assured themselves the backlash would be brief.
Income Investor: These Two Stocks Serve As Shelter In Market Storm
In a tough market, most stocks lose ground. Of all the stocks in IBD's database, only 27% were up year to date as of early Monday.
Abbott Agrees To Settle Lawsuit Over Price Of Antiretroviral Norvir
Abbott Laboratories on Wednesday agreed to pay between $10 million and $27.5 million to settle an antitrust lawsuit filed by HIV/AIDS advocates and other drug companies over an increase in the price of the ...